Skip to main content
. 2011 Feb 25;2(3):449–455. doi: 10.3892/etm.2011.218

Table I.

Patient characteristics.

MO17974 trial (n=12) ML18511 trial (n=9)
Age (years)
  18–64 8 5
  ≥65 4 4
Gender
  Male 8 6
  Female 4 3
Baseline PS (WHO)
  0 11 6
  1 1 3
  2 - -
Site of metastasis
  Liver 10 8
  Lung 1 4
  Node 7 7
  Other 2 1
(peritoneum) (serratus muscle)

PS, ECOG performance status.